September 14, 2015 Precompetitive Data Sharing as a Catalyst to Address Unmet Needs in Parkinson’s Disease Stephenson D, Hu MT, Romero K, Breen K, Burn D, Ben-Shlomo Y, Bhattaram A, Isaac M, Venuto C, Kubota K, Little MA, Friend S, Loves
September 2, 2015 Evidentiary Considerations for Integration of Biomarkers in Drug Development Symposium Evidentiary Considerations for Integration of Biomarkers in Drug Development Symposium On August 21st, the University of Maryland&
August 31, 2015 Collaboration is Making LIFE Better: Critical Path Institute Celebrates Key Milestones AZ Bionindustry Association
August 30, 2015 Critical Path Institute’s Polycystic Kidney Disease Outcomes Consortium Secures FDA Qualification for Enrichment Biomarker in Autosomal Dominant Polycystic Kidney Disease (ADPKD) August 31, 2015 Critical Path Institute’s Polycystic Kidney Disease Outcomes Consortium Secures FDA Qualification for Enrich
August 19, 2015 AZBio Honors Lynn Hudson, Ph.D. Of Critical Path Institute As 2015 Arizona Bioscience Leader August 19, 2015 AZBio Honors Lynn Hudson, Ph.D. Of Critical Path Institute As 2015 Arizona Bioscience Leader August 19, 2015 – C
August 17, 2015 An Evidence-Based Drug Development Tool for Tuberculosis Regimens: The Hollow Fiber System Model
August 17, 2015 New Clinical Infectious Diseases Journal Supplement Highlights Hollow Fiber System Model for Tuberculosis New Clinical Infectious Diseases Journal Supplement Highlights Hollow Fiber System Model for Tuberculosis The achievements
August 15, 2015 Forecasting Accuracy of the Hollow Fiber Model of Tuberculosis for Clinical Therapeutic Outcomes
